The Purified Protein Derivative (PPD) skin test, also known as the Mantoux tuberculin skin test, remains a cornerstone in tuberculosis (TB) screening worldwide. Despite newer blood-based tests, the PPD test continues to be widely used due to its accessibility, cost-effectiveness, and established reliability. This article provides a detailed examination of PPD testing, focusing on interpretation, clinical significance, and proper follow-up procedures.
Understanding the Image

The image presented shows a classic positive PPD test reaction on a patient’s forearm, demonstrating:
- Clear, measurable induration (raised, hardened area)
 - Professional measurement marking technique
 - Visible erythema (redness) surrounding the induration
 - Precise measurement guidelines
 - Well-documented reaction size
 - Characteristic appearance at the 48-72 hour reading window
 
PPD Test Fundamentals
Test Administration
- Injection Technique:
- Intradermal placement
 - 0.1 mL of 5 tuberculin units
 - Anterior forearm placement
 - Creation of small wheal
 - Proper needle angle (5-15 degrees)
 
 - Quality Control:
- Proper storage of tuberculin
 - Correct administration depth
 - Standardized technique
 - Documentation requirements
 
 
Interpretation Guidelines
- Timing Requirements:
- Optimal reading: 48-72 hours
 - No validity after 72 hours
 - Need for new test if deadline missed
 - Documentation of reading time
 
 - Measurement Criteria:
- ≥5mm considered positive in:
- HIV-positive individuals
 - Recent TB contacts
 - Organ transplant recipients
 - Immunosuppressed patients
 
 - ≥10mm considered positive in:
- Healthcare workers
 - Recent immigrants
 - Injection drug users
 - Residents of high-risk settings
 
 - ≥15mm considered positive in:
- Persons with no risk factors
 - Low-risk individuals
 - General population screening
 
 
 - ≥5mm considered positive in:
 
Clinical Significance and Risk Assessment
Factors Affecting Interpretation
- Patient History:
- Previous TB exposure
 - BCG vaccination status
 - Geographic risk factors
 - Occupational exposure
 - Medical conditions
 - Immunosuppression
 
 - Environmental Considerations:
- Living conditions
 - Work environment
 - Travel history
 - Community exposure
 - Healthcare setting exposure
 
 
False Results Understanding
- False Positive Causes:
- BCG vaccination
 - Non-tuberculous mycobacteria
 - Incorrect measurement
 - Technical errors
 - Cross-reactions
 
 - False Negative Causes:
- Recent TB infection
 - Very old TB infection
 - Young age
 - Live virus vaccination
 - Immunosuppression
 - Malnutrition
 
 
Follow-up Procedures
Immediate Actions
- Medical Evaluation:
- Comprehensive physical exam
 - Detailed medical history
 - Symptom assessment
 - Risk factor analysis
 
 - Additional Testing:
- Chest X-ray requirement
 - IGRA consideration
 - Sputum analysis if indicated
 - HIV testing when appropriate
 
 
Long-term Management
- Treatment Decisions:
- Preventive therapy options
 - Duration of treatment
 - Medication choices
 - Monitoring requirements
 
 - Ongoing Monitoring:
- Regular follow-up
 - Side effect assessment
 - Compliance checking
 - Treatment response evaluation
 
 
Prevention and Public Health
Preventive Strategies
- Regular Screening Programs:
- Healthcare worker monitoring
 - High-risk population screening
 - Contact investigations
 - Immigration requirements
 
 - Infection Control Measures:
- Workplace safety protocols
 - Personal protective equipment
 - Environmental controls
 - Education and training
 
 
Public Health Considerations
- Contact Tracing:
- Identification of exposed individuals
 - Screening protocols
 - Documentation requirements
 - Follow-up procedures
 
 - Reporting Requirements:
- Local health department notification
 - Documentation standards
 - Surveillance systems
 - Data collection protocols
 
 
Special Populations
High-Risk Groups
- Healthcare Workers:
- Annual screening requirements
 - Exposure protocols
 - Documentation needs
 - Follow-up procedures
 
 - Immunocompromised Patients:
- Modified interpretation criteria
 - Additional testing needs
 - Treatment considerations
 - Monitoring requirements
 
 
Conclusion
The PPD skin test remains a vital tool in tuberculosis screening and control. Proper understanding of test administration, interpretation, and follow-up procedures is essential for healthcare providers. A positive result, as demonstrated in the image, requires careful consideration of patient-specific factors and risk assessment to determine appropriate management strategies. Regular screening, proper documentation, and consistent follow-up are key components in effective tuberculosis control programs.
Note: This article is for educational purposes only. Always consult healthcare professionals for medical advice and interpretation of test results.
